Mandate

Vinge advises Transtema in connection with listing on Nasdaq Stockholm

Vinge has advised Transtema in connection with its application for admission to trading on Nasdaq Stockholm’s main list.

The Nasdaq Companies Committee approved the application on 17 September 2021, and Transtema published the prospectus on the same day. The first day of trading is planned to take place on 29 September.

Vinge’s team primarily consisted of Anders StridEdin Agic (Project Manager), Jacob BenzovLina André (Banking and Finance), Anna Backman (Employment Law), Alexander Lindeberg (IP/IT) and Anna Högsten (IP/IT)

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025